Researcher examines effect of exercise on breast cancer survivors
A researcher at Syracuse University has simple advice for breast cancer survivors struggling with the side effects of Aromatase Inhibitors (AIs): exercise.
Jan 18, 2017
0
7
A researcher at Syracuse University has simple advice for breast cancer survivors struggling with the side effects of Aromatase Inhibitors (AIs): exercise.
Jan 18, 2017
0
7
Postmenopausal women with breast cancer who took aromatase inhibitors demonstrated endothelial dysfunction, a predictor of cardiovascular disease, according to study results presented at the 2016 San Antonio Breast Cancer ...
Dec 12, 2016
0
20
A new study found that more socially isolated breast cancer survivors had higher rates of recurrence and mortality, while women with larger social networks experienced better outcomes. Published early online in Cancer, a ...
Dec 12, 2016
0
4
(HealthDay)—Women on breast cancer drugs called aromatase inhibitors may show signs of early blood vessel damage that could lead to heart disease, a small study suggests.
Dec 9, 2016
0
1
A sentinel lymph node biopsy (SLNB) during surgery that showed no signs of cancer was associated with a low risk for breast cancer recurrence in the axillary (armpit) lymph nodes for patients with large, operable breast tumors ...
Dec 7, 2016
0
1
In October, we mourned those who died of breast cancer and celebrated all of the women (and men) who have survived. What many of those survivors worry about, though, is that their breast cancer may come back. It has puzzled ...
Nov 15, 2016
0
64
A new study examines how one early example of precision medicine—tumor genome testing—is being used in women with breast cancer to reduce overtreatment and maximize the benefits of chemotherapy. Published early online ...
Oct 24, 2016
0
53
Researchers led by Johns Hopkins Kimmel Cancer Center scientists report they have developed a free web-based app that could take some of the guesswork out of decisions to order an additional and costly molecular test for ...
Oct 10, 2016
0
38
Early-stage breast cancer patients whose tumors carry genetic markers associated with a low risk of disease recurrence may not need to undergo chemotherapy, suggests a new study that employed a test devised by a UC San Francisco ...
Aug 25, 2016
0
79
In a new study from Kaiser Permanente, researchers found the use of aromatase inhibitors, hormone-therapy drugs used to treat patients with breast cancer, was not associated with an increased risk of fatal cardiovascular ...
Apr 21, 2016
0
2